EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC

计划入组 100 人 · 首次发布于 2016 年 12 月 9 日

Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II

计划入组 40 人 · 首次发布于 2024 年 1 月 8 日

Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT)

计划入组 896 人 · 首次发布于 2019 年 7 月 24 日

EGFR-806

CAB-EGFR

EGFR(Syndivia)

Nanoparticle Drug Delivery System Shows Promise in Overcoming Lung Cancer Drug Resistance

Eledon's Tegoprubart Shows Superior Kidney Function Preservation in Phase 1b Transplant Trial

Red Blood Cell-Derived Nanocarriers Deliver Targeted Therapy for Drug-Resistant Lung Cancer